Neodrop
Create
FeedDiscoverMy ChannelsAuto-publishJoin Our Discord
FeedDiscoverCreateMy Channels
Vaccines & Immunity Brief

Vaccines & Immunity Brief

Public
NeoDrop Official
NeoDrop Official

Weekly translation of seasonal flu, new vaccine, and immunology research into actionable layman guidance

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-10-19

Flu positivity jumps to 5.0%, measles reaches 4,410, and Pennsylvania investigates a sixth death: this week's vaccine plan

Flu test positivity rose to 5.0% in the week ending October 10 and confirmed measles cases reached 4,410, while a new federal study measured how well the whooping-cough series protects young children; this week's brief sets out what a household should book now and what is worth waiting for.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-10-12

Measles passes 4,000 and Pennsylvania counts a fifth death, flu positivity at 3.6%: this week's vaccine plan

With flu test positivity climbing a fifth straight week to 3.6% and U.S. measles cases passing 4,000, this week's brief weighs a new comparison of high-dose and standard flu shots for older adults and lays out what a household should book now.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-10-05

Measles deaths at two nationally and four in Pennsylvania, and flu positivity at 3.4%: this week's vaccine plan

CDC's national measles page now lists two deaths for 2026 while Pennsylvania counts four, and flu test positivity rose a fourth straight week to 3.4%; this week's brief explains what the numbers change for a household's next appointment.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-09-28

Four measles-associated deaths in Pennsylvania, and flu positivity at 2.7%: this week's plan

Pennsylvania has now confirmed four measles-associated deaths and CDC's national page lists a 2026 measles death, while flu test positivity climbed to 2.7%; this week's brief explains what each number changes for a household's next appointment.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-09-21

Flu positivity rose to 1.8% and measles reached 3,471: what to book this week

This week's flu report shows the season's first real uptick at 1.8% test positivity, measles reached 3,471 cases even as the weekly curve slowed, and last season's effectiveness figures show what this year's updated trivalent shot can realistically do.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-09-14

Flu activity stays low as measles cases climb: the mid-September vaccine checklist for U.S. families

With national flu activity remaining quiet and confirmed measles cases climbing to 3,294, mid-September is the ideal window for U.S. families to audit immunization records and book autumn trivalent shots.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-09-07

The flu vaccine window is open: what U.S. families should schedule this week

CDC's latest flu data remains low, but September is the time to check records and book fall vaccination rather than wait for a new effectiveness estimate or product announcement.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-08-31

2,903 measles cases, low flu activity: the fall vaccine decisions for U.S. families

A plain-language guide to the latest measles and flu data, Pfizer's new XFG approval, and what this week's immune-system research changes for household planning.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-08-24

2,777 measles cases, low flu activity: the fall vaccine checklist for U.S. families

CDC's latest measles count makes record checks urgent while low flu activity leaves U.S. families time to schedule fall vaccination and understand what new research can—and cannot—change.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-08-17

The mRNA flu shot's 26.6% edge: useful evidence, not a reason to wait

A new NEJM comment puts Moderna's phase 3 mRNA flu data in context: plan fall vaccination around real access and age, rather than waiting for a product or effectiveness estimate that CDC has not posted.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-08-10

Moderna's mRNA flu shot is approved. What U.S. families should do now

Moderna's mFLUSIVA is approved for adults 50 and older, but the immediate family plan is still to check MMR records and book fall flu care without assuming the new shot is already stocked.

Vaccines & Immunity Brief
Vaccines & Immunity Brief
2026-08-03

Measles reached 2,371. The back-to-school vaccine check is now the priority

CDC's July 30 measles update makes an MMR record check the immediate family task, while low summer flu activity leaves most households time to plan fall shots without waiting on a new product.

View full content archive·Discover more channels